+8618709260228
yingjia-victor@yingjia-bio.com
Haitian
English
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur
Lakay
Sou nou
Pwodwi yo
Nootropik
Bodybuilding
Pou Gason ak Fi
OEM & ODM
API
Nouvèl
Nouvèl endistri
Nouvèl konpayi
FAQ
Kontakte nou
Leave Your Message
Send
Sou entènèt
Mesaj
Telefòn
:+8618709260228
Imèl
:yingjia-victor@yingjia-bio.com
Whatsapp
:0086-13754992613
Lakay
Pwodwi yo
API
Kategori pwodwi yo
Nootropik
Bodybuilding
Pou Gason ak Fi
OEM & ODM
API
Pwodwi ki prezante yo
Tablèt Lenopril Otorize Kontwòl Tansyon ak Sante Kadyovaskilè
Telmisartan Pi bon antihypertensive Pwoteje ren
Flumazenil yon antagonist selektif reseptè GABAA ak aplikasyon ki ka geri li yo
Trametinib Kinase Inhibitor Vize BRAF V600 Mitasyon-Pozitif Kansè
Dabrafenib Yon Terapi vize pou kansè BRAF ki gen mitasyon
Tirzepatide Doub GLP-1 ak GIP agonist reseptè pou jesyon pwa ak kontwòl glisemi
Cisapride Stimulan gastric pou endijesyon ak maladi dijestif
YK-11 SARM ki pisan pou bati misk, pwogrè fòs, ak anpèchman myostatin
Ostarine (MK-2866) SARM versatile pou kwasans misk, pèt grès, ak rekonpozisyon kò
MK-677 Konpoze inik pou kwasans nan misk, andirans, ak rekiperasyon
01
02
03
04
05
API
01
Telmisartan Pi bon antihypertensive Pwoteje ren
2024-05-24
gade detay
01
Flumazenil yon antagonist selektif reseptè GABAA ak aplikasyon ki ka geri li yo
2024-05-22
gade detay
01
Trametinib Kinase Inhibitor Vize BRAF V600 Mitasyon-Pozitif Kansè
2024-05-19
gade detay
01
Dabrafenib Yon Terapi vize pou kansè BRAF ki gen mitasyon
2024-05-17
gade detay
01
Tirzepatide Doub GLP-1 ak GIP agonist reseptè pou jesyon pwa ak kontwòl glisemi
2024-05-16
gade detay
01
Cisapride Stimulan gastric pou endijesyon ak maladi dijestif
2024-05-13
gade detay
01
Òmòn Kwasans Imèn (HGH): Yon Zouti Pwisan pou Sante ak Fòm
2024-05-05
gade detay
01
Eledoisin Versatile Peptide kri materyèl Eledoisin Powder
2024-05-03
gade detay
01
Cetrorelix: Yon antagonis GnRH pou stimulation òvejyen kontwole ak maladi òmòn-sansib
2024-05-01
gade detay
01
Bivalirudin: Yon inibitè tronbin revèsib pou anticoagulation efikas
2024-05-01
gade detay
01
Atosiban anpeche nesans prematire
2024-04-30
gade detay
01
Vasopressin Multifaceted òmòn reglemante balans likid
2024-04-30
gade detay
01
Abarelix pwisan antagonist òmòn gonadotropin-divilge pou tretman kansè pwostat
2024-04-30
gade detay
01
Tropicamide Anticholinergic Ajan pou Egzamen Je ak Tretman Tropicamide Powder
2024-04-27
gade detay
01
Rosuvastatin ajan antilipemi Rosuvastatin trete dislipidemi
2024-04-23
gade detay
Premye
Prev
1
2
3
Next
Denye
Total 3